×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LXEO – lexeo therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/3
07:30 am
lxeo
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
Low
Report
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
2/28
04:28 pm
lxeo
Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference [Yahoo! Finance]
Low
Report
Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference [Yahoo! Finance]
2/13
05:28 pm
lxeo
Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript [Seeking Alpha]
Low
Report
Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript [Seeking Alpha]
2/5
07:30 am
lxeo
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February
Medium
Report
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February
2/2
10:00 am
lxeo
H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)'s PKP2 Program [Yahoo! Finance]
Low
Report
H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)'s PKP2 Program [Yahoo! Finance]
1/27
07:30 am
lxeo
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
Low
Report
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
1/13
09:03 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
Medium
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $17.00 price target on the stock.
1/13
07:17 am
lxeo
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Lexeo Therapeutics (NASDAQ:LXEO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/20
05:05 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Townsend Richard Nolan
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Townsend Richard Nolan
2/20
05:05 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Otero Jose Manuel
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Feb 18 Filed by: Otero Jose Manuel
2/20
05:05 pm
lxeo
Form 4/A Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Low
Report
Form 4/A Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
2/18
04:26 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Low
Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
2/18
03:51 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
Low
Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
2/18
03:34 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
Low
Report
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
2/18
03:28 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
Low
Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
2/18
03:28 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Low
Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: